Phase 2 Agitation Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2Phase 3
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH300 enrolled14 locationsNCT07284472
Recruiting
Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Alzheimer DiseaseAggressionAgitation,Psychomotor+2 more
IGC Pharma, LLC164 enrolled30 locationsNCT05543681
Recruiting
Phase 2
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Teikoku Pharma USA, Inc.150 enrolled3 locationsNCT06052254
Recruiting
Phase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Alzheimer DiseaseAgitation
Celgene120 enrolled52 locationsNCT06808984
Recruiting
Phase 2
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Agitation Associated With Alzheimer's Dementia
Intra-Cellular Therapies, Inc.320 enrolled69 locationsNCT06651567
Recruiting
Phase 2
A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia
Agitation Associated With Alzheimer's Disease Dementia
Ono Pharmaceutical Co., Ltd.90 enrolled38 locationsNCT06803823
Recruiting
Phase 2
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
Alzheimer DiseaseAgitation in Dementia
Bernard (Barry) Baumel8 enrolled1 locationNCT06781333
Recruiting
Phase 2Phase 3
Acute Agitation in Emergency Psychiatry
Agitation
Lone Baandrup132 enrolled1 locationNCT06752616
Recruiting
Phase 2
Dexmedetomidine versus standard of care for the management of severe agitation in patients at end of life.
Agitation
Dr Lana Ferguson20 enrolled1 locationACTRN12621001499875
Recruiting
Phase 2
Use of the antipsychotic olanzapine to treat agitation in traumatic brain injury
Post-traumatic amnesiaAgitation
Monash University58 enrolled1 locationACTRN12619000284167